$31.27
0.04[0.13%]
At close: Apr 25
$31.27
0[0.00%]
After Hours: 4:20PM EDT
Latest News for Perrigo Stock (NYSE:PRGO)
Perrigo Stock (NYSE: PRGO)
Categories: All
Thursday, April 25, 2024
Friday, April 12, 2024
Monday, April 08, 2024
Friday, April 05, 2024
Thursday, April 04, 2024
Tuesday, March 26, 2024
Monday, March 04, 2024
Friday, March 01, 2024
Thursday, February 29, 2024
Wednesday, February 28, 2024
Tuesday, February 27, 2024
- OTC Medicine Player Perrigo Outlines Three-Year Cost Saving Plan, Posts Mixed Q4 EarningsVandana Singh - Feb 27, 2024, 2:46PM
- Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Feb 27, 2024, 1:18PM
- Perrigo shares are trading lower after the company reported Q4 financial results.Benzinga Newsdesk - Feb 27, 2024, 9:23AM
- Perrigo Forecasts Fiscal Year 2024 Organic Net Sales Growth Of 1.0% To 3.0% YoY, With Reported Net Sales Flat And Expects Adjusted EPS Of $2.50-$2.65 Versus Consensus Of $3.00Benzinga Newsdesk - Feb 27, 2024, 6:37AM
- Perrigo Will Launch 'Project Energize' Investment And Efficiency Program In Q1 2024 To Drive Its One Perrigo Sustainable, Value Accretive Growth Strategy ; Restructuring Is Expected To Impact Approximately 6% Of Perrigo RolesBenzinga Newsdesk - Feb 27, 2024, 6:35AM
- Perrigo Q4 Adjusted EPS $0.86 Beats $0.83 Estimate, Sales $1.16B Miss $1.18B EstimateBenzinga Newsdesk - Feb 27, 2024, 6:32AM
- Earnings Scheduled For February 27, 2024Benzinga Insights - Feb 27, 2024, 5:01AM
Monday, February 26, 2024
Tuesday, December 19, 2023
Wednesday, December 13, 2023
Tuesday, November 28, 2023
Monday, November 20, 2023
Friday, November 17, 2023
Tuesday, November 07, 2023
- Perrigo Cuts Annual Guidance, This OTC Drug Firm Also Reports Mixed Q3 EarningsVandana Singh - Nov 7, 2023, 1:41PM
- Perrigo Lowered Guidance For Net Sales Growth To 4.0%-6.0% From 7.0%-11.0%Benzinga Newsdesk - Nov 7, 2023, 6:39AM
- Perrigo Revised FY23 Adj. EPS Outlook To $2.50-$2.60 (From $2.50-$2.70) Vs. Consensus $2.63Benzinga Newsdesk - Nov 7, 2023, 6:37AM
- Perrigo Q3 Adj. EPS $0.64 Beats $0.61 Estimate, Sales $1.12B Miss $1.20B EstimateBenzinga Newsdesk - Nov 7, 2023, 6:35AM
- Earnings Scheduled For November 7, 2023Benzinga Insights - Nov 7, 2023, 6:34AM
Monday, November 06, 2023
Friday, October 06, 2023
Tuesday, October 03, 2023
Tuesday, September 19, 2023
Wednesday, August 30, 2023
Wednesday, August 16, 2023
Wednesday, August 09, 2023
Tuesday, August 08, 2023
- Perrigo shares are trading higher after the company reported a Q2 earnings beat.Bill Haddad - Aug 8, 2023, 1:08PM
- Perrigo Sees FY23 EPS $0.50-$0.70Benzinga Newsdesk - Aug 8, 2023, 6:35AM
- Perrigo Q2 EPS $0.63 Beats $0.54 Estimate, Sales $1.19B Beat $1.18B EstimateBenzinga Newsdesk - Aug 8, 2023, 6:31AM
- Earnings Scheduled For August 8, 2023Benzinga Insights - Aug 8, 2023, 4:48AM
Wednesday, July 19, 2023
Thursday, July 13, 2023
- First Birth Control Pill For OTC Use In US Lands FDA ApprovalVandana Singh - Jul 13, 2023, 11:58AM
- Perrigo shares are trading higher after the company announced it received FDA approval for Opill, an OTC daily oral contraceptive.Benzinga Newsdesk - Jul 13, 2023, 9:01AM
- Perrigo Receives FDA Approval For Opill OTC Contraceptive PillBenzinga Newsdesk - Jul 13, 2023, 8:39AM